Abstract
Background Gastric cancer is a leading cause of cancer-related mortality, and current treatment outcomes for advanced disease remain poor. HER2 has been identified as a potential candidate for targeted therapy in gastric cancers displaying HER2 gene amplification and protein overexpression.
| Original language | English |
|---|---|
| Pages (from-to) | 839-842 |
| Number of pages | 4 |
| Journal | Journal of Clinical Pathology |
| Volume | 63 |
| Issue number | 9 |
| DOIs | |
| Publication status | Published - Sept 2010 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
ASJC Scopus subject areas
- Pathology and Forensic Medicine
Fingerprint
Dive into the research topics of 'A study of HER2 gene amplification and protein expression in gastric cancer'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver